Heritage Announces Dr. Spooner As Chief Science Officer

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.


Vancouver, B.C. / TheNewswire / October 16, 2018 – HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage or “Company”) is pleased to announce that Dr. Chris Spooner has joined the management team as Chief Science Officer.


Heritage is projecting that the cannabis industry will mirror the growth and development of the nutraceutical and integrative medicine industries, and Dr. Spooner’s clinical experience and insight in the areas of regulation and business development will prove incredibly useful in creating product lines, patient care protocols and customer satisfaction programs.


Dr. Spooner is a North Okanagan naturopathic doctor with extensive academic, clinical and business development experience. With over 20 years of experience owning and operating integrative care clinics, Dr. Spooner brings a targeted skill set that encompasses nutraceutical development, patient care protocols and clinic development. He is a member of numerous medical advisory boards, including of Atrium Innovations, a division of Nestlé Health Sciences, Translational Life Sciences and Kisameet Glacial Clay. In addition to this, Dr. Spooner has over a decade of experience on the board of directors of the College of Naturopathic Physicians of British Columbia.


Clint Sharples, Chairman and interim CEO says “We are excited to expand our management team to include Dr. Spooner. He is uniquely qualified and has ample experience to lead our efforts to become a significant participant in the quickly changing industry of natural health products. He brings both knowledge and existing agreements to our company, and will move us forward in this part of the business much quicker than on our own.”


About Heritage Cannabis Holdings Corp.

The Company is currently listed as a marijuana issuer having a 75% interest in PhyeinMed Inc, a Health Canada license holder under the ACMPR (Access to Cannabis for Medical Purposes Regulations). It is a Parent and Development Company with strategic plans to continue to acquire Cannabis related companies.




“Clint Sharples”


Clint Sharples

Chairman and interim CEO


For more information contact:

Clint Sharples

Tel: 416-705-8529



The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.


This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Copyright (c) 2018 TheNewswire - All rights reserved.